loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 21456 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 RABEPRAZOLE SODIUM (1)

filter

01 EISAI MEDCL RES (1)

filter

01 Tablet, Delayed Release; Oral (1)

filter

01 20MG (1)

filter

01 USA (1)

URL Supplier Web Content
Tablet, Delayed Releas...
20MG
ACIPHEX
USA
21456
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 21456

Looking for CTD TGA MCC DOSSIER APPLICATION 21456 1

19

Eisai, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RABEPRAZOLE SODIUM, with a corresponding application number 21456 and regulatory information .

proudly manufactured in the

Eisai's ACIPHEX Tablet, Delayed Release; Oral, medication with 20MG of RABEPRAZOLE SODIUM.

Post Enquiry
POST ENQUIRY